Biological Engineering

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2018

INQUIRY
Description
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2018

Hard Copy: 2900 USD 
PDF Copy (single user): 2900 USD
Enterprise wide License: 5800 USD
Pages: 126
Tables and Figures: 154
Published Date: Mar. 2018
Publisher: Biological Engineering Research Center
Contact: vivi@vkmarketresearch.com

Summary

This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.

The global Viral Vectors and Plasmid DNA Manufacturing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2025, growing at a CAGR of xx% between 2017 and 2025. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Viral Vectors and Plasmid DNA Manufacturing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx.

The major players in global Viral Vectors and Plasmid DNA Manufacturing market include
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Cell and Gene Therapy Catapult
Biovian
Brammer Bio

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share and Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2013 to 2025 (forecast), covering
North America
Europe 
Asia-Pacific 
South America 
Middle East & Africa

On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into 
Viral Vectors
Plasmid DNA

On the basis on the end users/applications, this report covers 
Cancers
Inherited Disorders
Viral Infections  
Others

Table of Contents

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview
1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Comparison by Types (2013-2025)
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Types in 2017
1.2.3 Viral Vectors
1.2.4 Plasmid DNA
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales Comparison by Applications (2013-2025)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2013-2025)
1.4.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2013-2025)
1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2013-2025)
1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2013-2025)
1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2013-2025)
1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size
1.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Status and Outlook (2013-2025)
1.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Status and Outlook (2013-2025)
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2013-2018)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2013-2018)
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Manufacturing Base Distribution, Sales Area, Product Types
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 and Top 10 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue by Regions
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Regions (2013-2018)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Regions (2013-2018)
3.3 Global Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
3.4 North America Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
3.5 Europe Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
3.6 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
3.7 South America Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
3.8 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2013-2018)
4 Global Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price Trend by Types
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales by Types (2013-2018)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Types (2013-2018)
4.3 Global Viral Vectors and Plasmid DNA Manufacturing Price by Type (2013-2018)
4.4 Global Viral Vectors and Plasmid DNA Manufacturing Sales Growth by Type (2013-2018)
5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Applications (2013-2018)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Applications (2013-2018)
6 Global Viral Vectors and Plasmid DNA Manufacturing Manufacturers Profiles/Analysis
6.1 BioReliance
6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Cobra Biologics
6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Oxford BioMedica
6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.3.4 Main Business/Business Overview
6.4 UniQure
6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.4.2.1 Product A
6.4.2.2 Product A
6.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.4.4 Main Business/Business Overview
6.5 FinVector
6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.5.4 Main Business/Business Overview
6.6 MolMed
6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.6.4 Main Business/Business Overview
6.7 MassBiologics
6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.7.4 Main Business/Business Overview
6.8 FUJIFILM Diosynth Biotechnologies
6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Lonza
6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Cell and Gene Therapy Catapult
6.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Category, End Uses and Specification
6.10.2.1 Type A
6.10.2.2 Type B
6.10.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price, Gross Margin and Market Share (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Biovian
6.12 Brammer Bio
7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis
7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue Forecast
11.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2018-2025)
11.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2018-2025)
11.1.3 Global Viral Vectors and Plasmid DNA Manufacturing Price and Trend Forecast (2018-2025)
11.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast by Regions (2018-2025)
11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast (2018-2025)
11.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast (2018-2025)
11.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast (2018-2025)
11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast (2018-2025)
11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Sales and Revenue Forecast (2018-2025)
11.3 Global Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price Forecast by Type (2018-2025)
11.4 Global Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Information Gathered via Interviews
13.4 Author List
13.5 Disclaimer